
Taxis Pharma receives $2.9 M NIH grant to develop therapeutic against antibiotic-resistant Gonorrhea
Taxis Pharma receives $2.9 M NIH grant to develop therapeutic against antibiotic-resistant Gonorrhea May 28, 2025 | Wednesday | News To further advance R&D efforts for its dihydrofolate reductase inhibitors image credit- shutterstock Taxis …